Page last updated: 2024-09-03

arginine-glycine-aspartate-o-methyltyrosine amide and fibrinogen

arginine-glycine-aspartate-o-methyltyrosine amide has been researched along with fibrinogen in 1 studies

Compound Research Comparison

Studies
(arginine-glycine-aspartate-o-methyltyrosine amide)
Trials
(arginine-glycine-aspartate-o-methyltyrosine amide)
Recent Studies (post-2010)
(arginine-glycine-aspartate-o-methyltyrosine amide)
Studies
(fibrinogen)
Trials
(fibrinogen)
Recent Studies (post-2010) (fibrinogen)
90334,4771,7077,083

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gorczynski, RJ; King, LW; Miyano, M; Nicholson, NS; Panzer-Knodle, SG; Salyers, AK; Taite, BB; Tjoeng, FS; Williams, MH; Zupec, ME1

Other Studies

1 other study(ies) available for arginine-glycine-aspartate-o-methyltyrosine amide and fibrinogen

ArticleYear
Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).
    The Journal of pharmacology and experimental therapeutics, 1991, Volume: 256, Issue:3

    Topics: Animals; Collagen; Dogs; Fibrinogen; Humans; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Thrombocytopenia

1991